Til hovedinnhold
English
Publikasjoner

Import of Live Leeches – Potential Risk to Norwegian Biodiversity

Vitenskapelig artikkel
Publiseringsår
2024
Tidsskrift
VKM Report
Eksterne nettsted
Cristin
NIVA-involverte
Paul Ragnar Berg
Forfattere
Martin Malmstrøm, Lawrence Richard Kirkendall, Kyrre Linné Kausrud, Paul Ragnar Berg, Anders Bryn, Kjetil Hindar, Johanna Järnegren, Anders Nielsen, Erlend Birkeland Nilsen, Brett Kevin Sandercock, Eva Bonsak Thorstad, Gaute Velle

Sammendrag

Import of leeches for medical use and hobby keeping poses a low risk of negative effects on Norwegian biodiversity. The two species of leeches (Hirudo medicinalis and H. verbana) have in recent years become more commonly used in Western medicine for various procedures where maintaining good blood flow is important. Hirudo medicinalis is considered native to Norway and is found in scattered populations in southern Norway. There is uncertainty about the genetic impact on these populations if imported leeches were to be released into the wild. Hirudo verbana is not registered in Norway but may have been imported as H. medicinalis in the past. Both species are listed under Appendix I, List B of the Norwegian CITES regulations. Methods VKM reviewed scientific literature to uncover potential negative effects in light of the leeches’ ecology under Norwegian conditions. VKM also investigated how the trade in live leeches is conducted, where they originate from, and outlined possible risk-reducing measures. VKM assessed four factors of potential relevance for negative impacts on biodiversity and conducted risk assessments for each: Hybridisation or other negative genetic impacts on local populations Competition with other leech species Parasitism or predation on amphibian populations Transmission of diseases Additionally, VKM assessed the extent of such imports and the likelihood of imported leeches ending up in Norwegian nature. Results VKM concluded that it is moderately likely that H. medicinalis will genetically affect Norwegian populations, but this will have minimal negative effects. Hybridisation between H. verbana and H. medicinalis is considered unlikely and would have little effect if it occurs. ”The leeches already present in Norway mainly originate from leeches imported from Europe in the 1800s. The introduction of new genes from the same areas now will therefore have minimal impact. The risk is therefore low,” says Lawrence Kirkendall, the scientific leader of the work. For parasitism or predation, amphibians are the main species that could theoretically be negatively affected by the leeches. VKM concludes that such negative effects are very unlikely and would have little or minimal impact. This implies low risk. Regarding competition and disease transmission, VKM assesses that these factors have little or minimal effect on biodiversity and are very unlikely. "We assess that the effects on biodiversity in Norway, if imported leeches were to end up in an environment where they thrive, are very small. At the same time, it is very unlikely that leeches used for medical procedures will end up in nature. The overall assessment is therefore that both species are associated with low risk of negative impact on biodiversity," says Kirkendall. The risk assessment is approved by the VKM Panel for Biodiversity.